Loteprednol Etabonate
Brand name: Loteprednol Etabonate
Rank #403 of 500 drugs by total cost
$22.1M
Total Cost
85,761
Total Claims
$22.1M
Total Cost
2,730
Prescribers
$258
Cost per Claim
35,526
Beneficiaries
108,332
30-Day Fills
$8,098
Avg Cost/Provider
31
Avg Claims/Provider
About Loteprednol Etabonate
Loteprednol Etabonate (sold as Loteprednol Etabonate) was prescribed 85,761 times by 2,730 Medicare Part D providers in 2023, costing the program $22.1M. At $258 per claim, this is a moderately priced medication.
Related Drugs by Cost
| # | Drug | Total Cost | Claims |
|---|---|---|---|
| 400 | Azithromycin (Azithromycin) | $22.2M | 3,009,458 |
| 401 | Torsemide (Torsemide) | $22.2M | 971,579 |
| 402 | Doxepin Hcl (Doxepin Hcl) | $22.2M | 371,255 |
| 403 | Loteprednol Etabonate (Loteprednol Etabonate) | $22.1M | 85,761 |
| 404 | Mycophenolate Mofetil (Mycophenolate Mofetil) | $22.0M | 152,937 |
| 405 | Tolterodine Tartrate (Tolterodine Tartrate Er) | $21.8M | 178,340 |
| 406 | Chlorthalidone (Chlorthalidone) | $21.8M | 966,780 |
Data from CMS Medicare Part D Prescriber-Drug Public Use File, 2023. Methodology